SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas - Aiming to improve therapy, outcomes, and validate a prospective frailty tool.
暂无分享,去创建一个
A. Alizadeh | Sonali M. Smith | J. Friedberg | M. Leblanc | L. Cerchietti | N. Henry | P. Caimi | R. Little | R. Olin | A. Beaven | H. Dillon | C. Laubach | Hongli Li | E. Brem | N. L. Henry | M. LeBlanc